In conclusion, our study indicates that Runx1t1 is essential for MYCN-driven tumorigenesis and has provided insight into the key role of this co-repressor not only in neuroblastoma initiation, but also in the progression of this childhood disease, and has opened avenues for the development of potential additional therapeutic treatment approaches. This evidence concerns the gene RUNX1T1 and neuroblastoma.